Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 +2.16%81 5-Year Yield-on-Cost % is 4.87 as of Aug. 17, 2026, which is 6% below its 10-year median of 5.16. GuruFocus rates TSE:9341 with a GF Score™ of 81/100 and a GF Value™ of 円2,014.36 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 317 Medical Devices & Instruments companies, Genova ranks better than 76.03% on this metric.
Genova's yield on cost for the quarter that ended in Mar. 2026 was 4.87.
The historical rank and industry rank for Genova's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:9341'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.76 Med: 5.16 Max: 5.43
Current: 4.87
During the past 6 years, Genova's highest Yield on Cost was 5.43. The lowest was 4.76. And the median was 5.16.
TSE:9341's 5-Year Yield-on-Cost % is ranked better than 76.03% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 2.29
vs TSE:9341: 4.87
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Genova 5-Year Yield-on-Cost % Related Terms
TSE:9341 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Genova's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Genova's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Genova is calculated as
Genova (TSE:9341) has a 5-Year Yield-on-Cost % of 4.87 as of Aug. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Genova and its competitors. This is near median its historical median of 5.16. Over the past decade, Genova's 5-Year Yield-on-Cost % has ranged from 4.76 to 5.43. According to the industry distribution chart, Genova ranks #76 out of 317 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is Genova's 5-Year Yield-on-Cost % too high?
Genova's current 5-Year Yield-on-Cost % of 4.87 is near median its 10-year median of 5.16. Over the past 10 years, this metric has ranged from a low of 4.76 to a high of 5.43. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.29. Genova's value of 4.87 is 112.7% above this industry median. Based on the distribution chart, Genova ranks #76 out of 317 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Genova has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #76 out of 317 companies for 5-Year Yield-on-Cost %. This places Genova in the top 24% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.29. Genova's value of 4.87 is 112.7% above this benchmark. Historically, Genova's own 5-Year Yield-on-Cost % has ranged from 4.76 to 5.43 over the past decade. While the company's 10-year median is 5.16 vs. the industry median of 2.29, Genova has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.29, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genova's current 5-Year Yield-on-Cost % of 4.87 is 112.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current 5-Year Yield-on-Cost % is 4.87, which is near median its own 10-year median of 5.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円2,014.36, compared to a current price of 円616.00 — trading 69.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 4.87, which is near median its 10-year median of 5.16 and 112.7% above the Medical Devices & Instruments industry median of 2.29. Genova's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Genova (TSE:9341), the current 5-Year Yield-on-Cost % is 4.87 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円616.00 is trading 69.4% below its estimated GF Value™ of 円2,014.36.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
5-Year Yield-on-Cost %: 4.87 (near median its 10-year median of 5.16)
GF Value™: 円2,014.36 vs. price of 円616.00 (69.4% below fair value)
Industry Position: 112.7% above the Medical Devices & Instruments median (#76 of 317)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
81GF Score
Get the complete analysis for TSE:9341
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
